Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (251-260 of 453) with videos related to

Pageof 46
Sort By:
Journal of Neuro-Oncology|November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECTMackenzie Price, Corey Neff, Carol Kruchko, et al.
Neuro-Oncology Practice|August 7, 2019
Association of genetic variants with fatigue in patients with malignant gliomaTerri S Armstrong, Elizabeth Vera, Renke Zhou, et al.
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Research|February 17, 2017
Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA RepairYanxin Lu, Jakub Kwintkiewicz, Yang Liu, et al.
Acta Neuropathologica Communications|July 10, 2020
High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymomaMark Raffeld, Zied Abdullaev, Svetlana D Pack, et al.
Cancer Letters|December 5, 2017
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiationWinson S Ho, Saman Sizdahkhani, Shuyu Hao, et al.
Neuro-Oncology|December 7, 2013
Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiationChristian L Barney, Aaron P Brown, David R Grosshans, et al.
Biophysical Journal|November 15, 2020
A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue CulturesRea Ravin, Teddy X Cai, Randall H Pursley, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System TumorAlvina Acquaye-Mallory, Gary Rodin, Madhura Managoli, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Pageof 46

Showing results (251-260 of 453) with videos related to

Sort By:
Pageof 46
Journal of Neuro-Oncology|November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECTMackenzie Price, Corey Neff, Carol Kruchko, et al.
Neuro-Oncology Practice|August 7, 2019
Association of genetic variants with fatigue in patients with malignant gliomaTerri S Armstrong, Elizabeth Vera, Renke Zhou, et al.
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Research|February 17, 2017
Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA RepairYanxin Lu, Jakub Kwintkiewicz, Yang Liu, et al.
Acta Neuropathologica Communications|July 10, 2020
High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymomaMark Raffeld, Zied Abdullaev, Svetlana D Pack, et al.
Cancer Letters|December 5, 2017
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiationWinson S Ho, Saman Sizdahkhani, Shuyu Hao, et al.
Neuro-Oncology|December 7, 2013
Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiationChristian L Barney, Aaron P Brown, David R Grosshans, et al.
Biophysical Journal|November 15, 2020
A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue CulturesRea Ravin, Teddy X Cai, Randall H Pursley, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System TumorAlvina Acquaye-Mallory, Gary Rodin, Madhura Managoli, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Pageof 46